Skip to main content
Explore URMC


Ovarian Cancer: A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Research Question:
Can niraparib help delay worsening of cancer among patients who had a good response to previous treatment with a platinum-type chemotherapy drug?

Basic Study Information

If you agree to be in this study, you will either take the Study Drug, niraparib, capsules or placebo capsules by mouth once daily. You have a 2 in 3 chance of receiving study drug. Neither you or your study doctor will know if you receive niraparib or placebo.

Location: Cancer Center
Study Web URL:
Study Reference #: IGYO17056

Lead Researcher (Principal Investigator)

Lead Researcher: Richard Moore

Study Contact Information

Study Coordinator: Laura Mitchell
Phone: (585) 275-7763

Additional Study Details

Return to Search